A Study of Imatinib and Valproic Acid in Patients With Chronic Myelogenous Leukemia (CML)
Status:
Withdrawn
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to test the effect of the combination of valproate in combination
with imatinib with an aim of achieving a maximal molecular response as the primary goal.